| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Interim CFO | President | Director
2 companies
Gallagher Cam is a President, Interim CFO at Opus Genetics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $12.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2020 | ZNTL Zentalis Pharmaceuticals, Inc. | Director | Sell | 10,000 | $46.54 | $465,381.07 | -0.8% | |
| Nov 19, 2020 | IRD Opus Genetics, Inc. | Director | Buy | 8,865 | $0.00 | - | +61.2% |